IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, Monday announced the appointment of Joshua Bleharski as chief financial officer.
Before joining IDEAYA, Bleharski was Managing Director and Global Co-Head of Biopharma at J.P. Morgan's Healthcare Investment Banking group for 17 years. IDEAYA expects Bleharski to fully transition into his new role by early May.
In the pre-market trading, IDEAYA Biosciences is 1.83% lesser at $22.58 on the Nasdaq.
For comments and feedback: editorial@rttnews.com